Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Zoetis Total Long-Term Assets 2011-2024 | ZTS

Zoetis total long-term assets from 2011 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
  • Zoetis total long-term assets for the quarter ending June 30, 2024 were $7.963B, a 5.25% increase year-over-year.
  • Zoetis total long-term assets for 2023 were $7.943B, a 7.06% increase from 2022.
  • Zoetis total long-term assets for 2022 were $7.419B, a 6.44% increase from 2021.
  • Zoetis total long-term assets for 2021 were $6.97B, a 0.4% decline from 2020.
  
Zoetis Annual Total Long-Term Assets
(Millions of US $)
2023 $7,943
2022 $7,419
2021 $6,970
2020 $6,998
2019 $6,797
2018 $6,378
2017 $4,369
2016 $4,259
2015 $4,083
2014 $3,123
2013 $3,201
2012 $3,398
2011 $3,400
2010 $
Zoetis Quarterly Total Long-Term Assets
(Millions of US $)
2024-06-30 $7,963
2024-03-31 $7,989
2023-12-31 $7,943
2023-09-30 $7,884
2023-06-30 $7,566
2023-03-31 $7,485
2022-12-31 $7,419
2022-09-30 $7,123
2022-06-30 $7,119
2022-03-31 $7,023
2021-12-31 $6,970
2021-09-30 $7,023
2021-06-30 $7,021
2021-03-31 $7,002
2020-12-31 $6,998
2020-09-30 $6,968
2020-06-30 $6,784
2020-03-31 $6,756
2019-12-31 $6,797
2019-09-30 $6,654
2019-06-30 $6,502
2019-03-31 $6,504
2018-12-31 $6,378
2018-09-30 $6,383
2018-06-30 $4,364
2018-03-31 $4,423
2017-12-31 $4,369
2017-09-30 $4,394
2017-06-30 $4,218
2017-03-31 $4,266
2016-12-31 $4,259
2016-09-30 $4,351
2016-06-30 $4,190
2016-03-31 $4,146
2015-12-31 $4,083
2015-09-30 $3,236
2015-06-30 $3,282
2015-03-31 $3,320
2014-12-31 $3,123
2014-09-30 $3,174
2014-06-30 $3,195
2014-03-31 $3,181
2013-12-31 $3,201
2013-09-30 $3,176
2013-06-30 $3,179
2013-03-31 $3,200
2012-12-31 $3,398
2012-09-30
2012-06-30
2012-03-31
2011-12-31 $4,306
2010-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $89.015B $8.544B
Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $47.155B 9.44
Merck (MKGAF) Germany $23.651B 25.81
Astellas Pharma (ALPMY) Japan $22.060B 26.50
Summit Therapeutics (SMMT) United States $17.795B 0.00
Sandoz Group AG (SDZNY) Switzerland $17.649B 0.00
United Therapeutics (UTHR) United States $15.242B 15.74
Shionogi (SGIOY) Japan $13.107B 12.56
Neurocrine Biosciences (NBIX) United States $12.102B 36.21
Catalent (CTLT) United States $10.946B 0.00
Orion OYJ (ORINY) Finland $7.423B 30.23
Revolution Medicines (RVMD) United States $7.360B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.766B 7.18
Ionis Pharmaceuticals (IONS) United States $6.194B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.660B 0.00
Madrigal Pharmaceuticals (MDGL) United States $5.063B 0.00
Corcept Therapeutics (CORT) United States $4.417B 37.41
Crinetics Pharmaceuticals (CRNX) United States $4.223B 0.00
Dyne Therapeutics (DYN) United States $3.448B 0.00
PTC Therapeutics (PTCT) United States $2.729B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.696B 15.55
Arrowhead Pharmaceuticals (ARWR) United States $2.583B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.425B 19.27
Soleno Therapeutics (SLNO) United States $2.082B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.942B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.780B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.647B 0.00
Xencor (XNCR) United States $1.625B 0.00
Harrow (HROW) United States $1.608B 0.00
Cassava Sciences (SAVA) United States $1.455B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.436B 0.00
Ocular Therapeutix (OCUL) United States $1.411B 0.00
Ardelyx (ARDX) United States $1.389B 0.00
ARS Pharmaceuticals (SPRY) United States $1.362B 0.00
Indivior (INDV) United States $1.347B 6.18
Avadel Pharmaceuticals (AVDL) Ireland $1.314B 0.00
Evotec AG (EVO) Germany $1.290B 0.00
Collegium Pharmaceutical (COLL) United States $1.249B 7.17
Calliditas Therapeutics AB (CALT) Sweden $1.200B 0.00
Enliven Therapeutics (ELVN) United States $1.028B 0.00
Relay Therapeutics (RLAY) United States $1.015B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.013B 0.00
Bioventus (BVS) United States $0.947B 30.76
4D Molecular Therapeutics (FDMT) United States $0.874B 0.00
Cronos Group (CRON) Canada $0.868B 0.00
USANA Health Sciences (USNA) United States $0.759B 13.92
Savara (SVRA) United States $0.731B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.722B 45.20
ProKidney (PROK) United States $0.692B 0.00
Pacira BioSciences (PCRX) United States $0.676B 6.40
Exscientia (EXAI) United Kingdom $0.631B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.594B 0.00
Siga Technologies (SIGA) United States $0.569B 6.81
Silence Therapeutics (SLN) United Kingdom $0.546B 0.00
OmniAb (OABI) United States $0.545B 0.00
Tourmaline Bio (TRML) United States $0.538B 0.00
Eliem Therapeutics (ELYM) United States $0.535B 0.00
Foghorn Therapeutics (FHTX) United States $0.529B 0.00
Altimmune (ALT) United States $0.528B 0.00
Verve Therapeutics (VERV) United States $0.466B 0.00
Sage Therapeutics (SAGE) United States $0.463B 0.00
KalVista Pharmaceuticals (KALV) United States $0.462B 0.00
Aquestive Therapeutics (AQST) United States $0.451B 0.00
Larimar Therapeutics (LRMR) United States $0.437B 0.00
Xeris Biopharma Holdings (XERS) United States $0.432B 0.00
Elite Pharmaceuticals (ELTP) United States $0.414B 38.75
Zevra Therapeutics (ZVRA) United States $0.412B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.405B 0.00
Organogenesis (ORGO) United States $0.378B 0.00
Aldeyra Therapeutics (ALDX) United States $0.349B 0.00
Lyell Immunopharma (LYEL) United States $0.346B 0.00
Korro Bio (KRRO) United States $0.342B 0.00
Esperion Therapeutics (ESPR) United States $0.341B 0.00
Lexeo Therapeutics (LXEO) United States $0.317B 0.00
Heron Therapeutics (HRTX) United States $0.296B 0.00
Akebia Therapeutics (AKBA) United States $0.284B 0.00
Avita Medical (RCEL) United States $0.271B 0.00
ESSA Pharma (EPIX) Canada $0.268B 0.00
Black Diamond Therapeutics (BDTX) United States $0.267B 0.00
Nature's Sunshine Products (NATR) United States $0.251B 17.14
Enanta Pharmaceuticals (ENTA) United States $0.241B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.240B 0.00
Acrivon Therapeutics (ACRV) United States $0.234B 0.00
Nanobiotix S.A (NBTX) France $0.232B 0.00
Nektar Therapeutics (NKTR) United States $0.232B 0.00
Pyxis Oncology (PYXS) United States $0.216B 0.00
CytoDyn (CYDY) United States $0.199B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.196B 0.00
MediWound (MDWD) Israel $0.190B 0.00
Innate Pharma SA (IPHYF) France $0.184B 0.00
Profound Medical (PROF) Canada $0.184B 0.00
Telomir Pharmaceuticals (TELO) United States $0.178B 0.00
Galectin Therapeutics (GALT) United States $0.169B 0.00
VAXART, INC (VXRT) United States $0.160B 0.00
Cardiol Therapeutics (CRDL) Canada $0.154B 0.00
Achieve Life Sciences (ACHV) Canada $0.151B 0.00
Context Therapeutics (CNTX) United States $0.147B 0.00
Century Therapeutics (IPSC) United States $0.140B 0.00
Prelude Therapeutics (PRLD) United States $0.134B 0.00
OptiNose (OPTN) United States $0.128B 0.00
Fractyl Health (GUTS) United States $0.128B 0.00
Assertio Holdings (ASRT) United States $0.124B 21.67
Incannex Healthcare (IXHL) Australia $0.117B 0.00
Journey Medical (DERM) United States $0.106B 0.00
Regulus Therapeutics (RGLS) United States $0.106B 0.00
Relmada Therapeutics (RLMD) United States $0.105B 0.00
CASI Pharmaceuticals (CASI) China $0.105B 0.00
Metagenomi (MGX) United States $0.100B 0.00
Citius Pharmaceuticals (CTXR) United States $0.092B 0.00
Karyopharm Therapeutics (KPTI) United States $0.092B 0.00
AlloVir (ALVR) United States $0.088B 0.00
Aclaris Therapeutics (ACRS) United States $0.083B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.083B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.079B 0.00
Arch Biopartners (ACHFF) Canada $0.078B 0.00
PMV Pharmaceuticals (PMVP) United States $0.078B 0.00
Swiftmerge Acquisition (IVCP) United States $0.076B 368.33
Vivani Medical (VANI) United States $0.067B 0.00
SCYNEXIS (SCYX) United States $0.059B 0.00
Mural Oncology (MURA) Ireland $0.059B 0.00
Champions Oncology (CSBR) United States $0.058B 0.00
Nutriband (NTRB) United States $0.056B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.050B 0.00
BioLineRx (BLRX) Israel $0.050B 0.00
Inotiv (NOTV) United States $0.048B 0.00
ProPhase Labs (PRPH) United States $0.047B 0.00
FibroGen (FGEN) United States $0.042B 0.00
DURECT (DRRX) United States $0.042B 0.00
Carisma Therapeutics (CARM) United States $0.042B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.041B 0.00
Rafael Holdings (RFL) United States $0.041B 0.00
Natural Alternatives (NAII) United States $0.040B 0.00
Protara Therapeutics (TARA) United States $0.040B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Gain Therapeutics (GANX) United States $0.038B 0.00
Unicycive Therapeutics (UNCY) United States $0.037B 0.00
Tempest Therapeutics (TPST) United States $0.036B 0.00
Enlivex Therapeutics (ENLV) Israel $0.033B 0.00
Oruka Therapeutics (ORKA) United States $0.031B 0.00
VYNE Therapeutics (VYNE) United States $0.027B 0.00
Lipocine (LPCN) United States $0.027B 0.00
Surrozen (SRZN) United States $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.025B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.025B 0.00
MEI Pharma (MEIP) United States $0.020B 0.78
Minerva Neurosciences (NERV) United States $0.020B 0.00
Cosmos Health (COSM) United States $0.020B 0.00
TherapeuticsMD (TXMD) United States $0.019B 0.00
BioVie (BIVI) United States $0.018B 0.00
Lyra Therapeutics (LYRA) United States $0.018B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.018B 0.00
NRx Pharmaceuticals (NRXP) United States $0.017B 0.00
PolyPid (PYPD) Israel $0.017B 0.00
Talphera (TLPH) United States $0.015B 0.00
Nuvilex (PMCB) United States $0.015B 0.00
Indaptus Therapeutics (INDP) United States $0.014B 0.00
Mannatech (MTEX) United States $0.014B 0.00
Vivos Therapeutics (VVOS) United States $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Conduit Pharmaceuticals (CDT) United States $0.013B 0.00
Redhill Biopharma (RDHL) Israel $0.012B 0.00
Dominari Holdings (DOMH) United States $0.012B 0.00
Aptorum Group (APM) United Kingdom $0.012B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.011B 0.00
GlycoMimetics (GLYC) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Jaguar Animal Health (JAGX) United States $0.010B 0.00
Plus Therapeutics (PSTV) United States $0.010B 0.00
Avalo Therapeutics (AVTX) United States $0.009B 0.00
Molecular Templates (MTEM) United States $0.009B 0.00
Inhibikase Therapeutics (IKT) United States $0.009B 0.00
Viracta Therapeutics (VIRX) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Biomerica (BMRA) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Oncternal Therapeutics (ONCT) United States $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
Ainos (AIMD) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.11
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (BGM) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 3.48
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 36.56